soulstice logo Exploring a deeper approach


Sherri Z. Millis, Ph.D.

Phone: (808) 341-9047
E-mail:
sherri.millis@gmail.com

20 years of clinical and industry experience in areas of the Drug Discovery/Development Pathway, as shown in table below. Clients include large-to medium-sized pharma to startup biotechs.

Key Areas of Expertise

  • Biochemical and cell based assay development
  • HTS
  • Enzymology
  • Fluorescence technologies
  • Grant writing and review
  • CRO management

Drug Discovery/Development Pathway Experience

Target Validation Lead Discovery Compound Optimization
  • Biology
  • Molecular Biology
  • Biochemistry
  • Assay Development
  • HTS
  • Enzymology
  • Biochemistry
  • Chemistry
  • Structural Biology
  • Biochemistry
  • ADMET
Safety Assessment Animal Models Pre-, Clinical Trials
  • Animal Pharmacology
  • In vivo ADMET
  • Pathology
  • In vivo ADMET
  • Animal Pharmacology
  • Biochemistry
  • Safety
  • Toxicity
  • Efficacy